Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nalbuphine for Opioid Induced Pruritus in Children
NCT00323154Phase 3Completed
- Sponsor
- University of British Columbia
- Start
- Mar 2004
- Primary completion
- Dec 2004
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of nalbuphine in pruritus, sponsored by University of British Columbia. Started Mar 2004; status: completed.
02
Drugs
nalbuphine
03
Conditions
pruritus
Beyond the preview
Go deeper on NCT00323154.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00323154.